BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Y, Zheng S, Yao J, Li M, Yang G, Zhang N, Zhang S, Zhong B. Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma. Oncotarget 2017;8:3018-28. [PMID: 27935871 DOI: 10.18632/oncotarget.13822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Dutra TTB, Bezerra TMM, Luna ECM, Carvalho FSR, Chaves FN, Barros Silva PG, Costa FWG, Pereira KMA. Do Protocadherins Show Prognostic Value in the Carcinogenesis of Human Malignant Neoplasms? Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev 2020;21:3677-88. [PMID: 33369468 DOI: 10.31557/APJCP.2020.21.12.3677] [Reference Citation Analysis]
2 Luo Y, Ye J, Wei J, Zhang J, Li Y. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma. Mol Med Rep 2020;22:997-1007. [PMID: 32468063 DOI: 10.3892/mmr.2020.11179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Chauhan R, Shimizu Y, Watashi K, Wakita T, Fukasawa M, Michalak TI. Retrotransposon elements among initial sites of hepatitis B virus integration into human genome in the HepG2-NTCP cell infection model. Cancer Genet 2019;235-236:39-56. [PMID: 31064734 DOI: 10.1016/j.cancergen.2019.04.060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sui J, Miao Y, Han J, Nan H, Shen B, Zhang X, Zhang Y, Wu Y, Wu W, Liu T, Xu S, Yang S, Yin L, Pu Y, Liang G. Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma. Cancer Med 2018. [PMID: 29761859 DOI: 10.1002/cam4.1541] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
5 Gong Z, Hu G. PCDH20 acts as a tumour-suppressor gene through the Wnt/β-catenin signalling pathway in hypopharyngeal squamous cell carcinoma. Cancer Biomark 2019;26:209-17. [PMID: 31450490 DOI: 10.3233/CBM-190442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]